Find out how NAMs are influencing safety assessments and decision-making in the pharmaceutical industry ahead of 2026.
Explore the role of the cPLA2 enzyme in brain inflammation related to Alzheimer’s disease and its potential as a therapeutic target.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results